[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360672-105":59,"doc-detail-360672-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","exploring-the-correlation-between-mean-platelet-volume-to-lymphocyte-ratio-and-all-cause-and-cardiovascular-mortality-in-cancer-patients-data-from-the-nhanes-study","Exploring the correlation between mean platelet volume-to-lymphocyte ratio and all-cause and cardiovascular mortality in cancer patients - Data from the NHANES study","","Mean platelet volume-to-lymphocyte ratio (MPVLR), a composite marker reflecting inflammation and immune function, is of unclear prognostic value in cancer. This observational study analyzed adult cancer patients with complete records from NHANES (1999–2018), using Cox proportional hazards models to assess associations between MPVLR and all-cause and cardiovascular disease (CVD) mortality, plus Kaplan–Meier curves. Restricted cubic splines, threshold and subgroup analyses were performed, including age, sex, race, comorbidities, and lifestyle factors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/exploring-the-correlation-between-mean-platelet-volume-to-lymphocyte-ratio-and-all-cause-and-cardiovascular-mortality-in-cancer-patients-data-from-the-nhanes-study/360672/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/exploring-the-correlation-between-mean-platelet-volume-to-lymphocyte-ratio-and-all-cause-and-cardiovascular-mortality-in-cancer-patients-data-from-the-nhanes-study/360672.png","ImageObject",300,407,{"name":92,"@type":93},"Franzy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on MPVLR in cancer patients?","Question",{"text":112,"@type":113},"To evaluate whether mean platelet volume-to-lymphocyte ratio (MPVLR) is associated with all-cause mortality and cardiovascular mortality among adult cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study analyze the relationship between MPVLR and mortality?",{"text":117,"@type":113},"It used Cox proportional hazards models for association testing, Kaplan–Meier survival curves for group prognosis comparison, and restricted cubic spline/threshold and subgroup analyses to explore nonlinear and subgroup effects.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings regarding MPVLR and risk of death?",{"text":121,"@type":113},"Higher MPVLR levels were associated with increased all-cause and CVD mortality risk, and the association showed a nonlinear pattern in cancer patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360672,1790193738,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","®  \n Observational Study   \nExploring the correlation between mean platelet volume-to-lymphocyte ratio and all-cause and cardiovascular mortality in cancer patients Data from the NHANES study  \nPing Lin, MMa ,* , Jihuang Wang, MBa , Wenfeng Xie, MBa , Siyi Xiu, MMa , Xiaoping Huang, MBb  \n\n| Abstract\u003Cbr>The relationship between the mean platelet volume-to-lymphocyte ratio (MPVLR), a composite indicator of the body’s inflammatory response and immune function, and the prognosis of cancer patients is unclear. A total of adult cancer patients with complete information between 1999 and 2018 were included in this study. The Cox proportional hazards model was used to investigate the association between MPVLR levels and all-cause and cardiovascular disease (CVD) mortality in adult cancer patients. The probability of all-cause and CVD mortality in cancer patients with different MPVLR levels was compared by plotting Kaplan–Meier survival curves. Restricted cubic spline analysis, threshold effect analysis, and subgroup analysis were also used. This study ultimately included a total of 3997 adult cancer patients, with a median age of 69 years. During a median follow-up period of 7.08 years, a total of 1379 (34 .50%) all-cause deaths and 299 (7 .48%) deaths from CVD occurred. According to the Cox proportional hazards model analysis, MPVLR was associated with all-cause mortality rate (hazard ratio [95% confidence interval]: 1.13 [1 .11–1. 16], P \u003C .001) and a CVD mortality rate (hazard ratio [95% confidence interval]: 1.16 [1 .11–1.20], P \u003C .001), which were significantly associated with an increased risk of mortality. Kaplan–Meier survival curve analyses showed that the prognosis of the high-level MPVLR group was significantly worse than that of the low-level group. This association persisted in subgroup analyses based on age, sex, race, marital status, education level, ratio of family income to poverty, body mass index, smoking status, drinking status, hypertension, and diabetes. Restricted cubic spline analysis models showed a nonlinear association between MPVLR and all-cause or CVD mortality in adult cancer patients. Higher MPVLR levels were significantly associated with an increased risk of all-cause and CVD mortality in adult cancer patients. There was a nonlinear relationship between MPVLR and all-cause or CVD mortality in adult cancer patients.\u003Cbr>Abbreviations: BMI = body mass index, CI = confidence interval, CVD = cardiovascular disease, HR = hazard ratio, MPV = mean platelet volume, MPVLR = mean platelet volume-to-lymphocyte ratio, NCHS = National Center for Health Statistics, NHANES = National Health and Nutrition Examination Survey, OS = overall survival, PIR = ratio of family income to poverty. |\n| --- |\n| Keywords: all-cause mortality, cancer, cardiovascular disease mortality, mean platelet volume-to-lymphocyte ratio, NHANES |\n\n1. Introduction  \nAfter cardiovascular disease (CVD), cancer has become the second leading cause of death worldwide. Although cancer and CVD are 2 different types of diseases, they share similar risk factors, such as chronic inflammation, which is oneof the most important factors in the development and progression of cancer and CVD. [1] With the continuous advancement of cancer early screening and treatment technologies, as well as the aging of the population, it is expected that by 2025, there will be nearly 2.04 million new cancer cases and  \nnearly 0.62 million cancer deaths, according to US cancer statistics. [2] There is increasing evidence that chronic inflammatory responses are closely related to the development of CVD and cancer, and that inflammation-related factors may serve as effective predictors of cancer prognosis. For example, systemic inflammatory markers such as interleukin-6, systemic immunoinflammatory index, and neutrophil-to-lymphocyte ratio have been shown to be closely associated with cancer development and prognosis. [3]  \nMean platelet volume (MPV)-to-lymphocyte ratio (MPVLR) i","cbCaieWqM8EVFKsM","https://ap.wps.com/l/cbCaieWqM8EVFKsM","pdf",1506241,"English","# Introduction\n## Study background and rationale\n## Overview of MPVLR as a prognostic marker\n# Methods\n## Study design and data source (NHANES)\n## Statistical analyses (Cox model, Kaplan–Meier, splines)","[{\"question\":\"What is the main goal of the study on MPVLR in cancer patients?\",\"answer\":\"To evaluate whether mean platelet volume-to-lymphocyte ratio (MPVLR) is associated with all-cause mortality and cardiovascular mortality among adult cancer patients.\"},{\"question\":\"How did the study analyze the relationship between MPVLR and mortality?\",\"answer\":\"It used Cox proportional hazards models for association testing, Kaplan–Meier survival curves for group prognosis comparison, and restricted cubic spline/threshold and subgroup analyses to explore nonlinear and subgroup effects.\"},{\"question\":\"What were the key findings regarding MPVLR and risk of death?\",\"answer\":\"Higher MPVLR levels were associated with increased all-cause and CVD mortality risk, and the association showed a nonlinear pattern in cancer patients.\"}]","Exploring the correlation between mean platelet volume-to-lymphocyte ratio and all-cause and cardiovascular mortality in cancer patients - Data from the NHANES study | PDF",1790141040,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd33e9b14a7f02d728efd60afe2ac0ce.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81362e31059f8d09d1c34190ec53f785.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c28df98f4af67efd550fc9244c398ea8.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad716031472c7a24638678b120d68583.webp",980,1306]